97 related articles for article (PubMed ID: 9186709)
1. Modulation of the autoimmune response in lupus mice by oral administration of attenuated Salmonella typhimurium expressing the IL-2 and TGF-beta genes.
Huggins ML; Huang FP; Xu D; Lindop G; Stott DI
Ann N Y Acad Sci; 1997 Apr; 815():499-502. PubMed ID: 9186709
[No Abstract] [Full Text] [Related]
2. Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-beta1 gene therapy using attenuated Salmonella typhimurium as gene carrier.
Huggins ML; Huang FP; Xu D; Lindop G; Stott DI
Lupus; 1999; 8(1):29-38. PubMed ID: 10025597
[TBL] [Abstract][Full Text] [Related]
3. IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus.
Dai H; He F; Tsokos GC; Kyttaris VC
J Immunol; 2017 Aug; 199(3):903-910. PubMed ID: 28646040
[TBL] [Abstract][Full Text] [Related]
4. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus.
Gutierrez-Ramos JC; Andreu JL; Revilla Y; Viñuela E; Martinez C
Nature; 1990 Jul; 346(6281):271-4. PubMed ID: 1973822
[TBL] [Abstract][Full Text] [Related]
5. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
6. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells.
Luzina IG; Knitzer RH; Atamas SP; Gause WC; Papadimitriou JC; Sztein MB; Storrer CE; Handwerger BS
Arthritis Rheum; 1999 Mar; 42(3):561-8. PubMed ID: 10088780
[TBL] [Abstract][Full Text] [Related]
7. Modulation of intra-pulmonary TGF-beta expression by mycophenolate mofetil in lupus prone MRL/lpr mice.
Guo H; Leung JC; Chan LY; Lui SL; Tsang AW; Lai KN
Lupus; 2005; 14(8):583-92. PubMed ID: 16175929
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
9. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
[TBL] [Abstract][Full Text] [Related]
10. Expression of TGF-beta in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammation, IL-2 and IFN-gamma, but enhancement of IL-10, in carrageenin-induced oedema in mice.
Ianaro A; Xu D; O'Donnell CA; Di Rosa M; Liew FY
Immunology; 1995 Jan; 84(1):8-15. PubMed ID: 7890306
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
Rodgers KE
J Autoimmun; 1997 Aug; 10(4):367-73. PubMed ID: 9237800
[TBL] [Abstract][Full Text] [Related]
12. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity.
Pollard KM; Pearson DL; Hultman P; Hildebrandt B; Kono DH
Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):729-35. PubMed ID: 10502538
[TBL] [Abstract][Full Text] [Related]
13. T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus.
Düster M; Becker M; Gnirck AC; Wunderlich M; Panzer U; Turner JE
Eur J Immunol; 2018 Aug; 48(8):1364-1375. PubMed ID: 29671873
[TBL] [Abstract][Full Text] [Related]
14. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
15. FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus.
Shi D; Tian T; Yao S; Cao K; Zhu X; Zhang M; Wen S; Li L; Shi M; Zhou H
Brain Behav Immun; 2018 May; 70():293-304. PubMed ID: 29548997
[TBL] [Abstract][Full Text] [Related]
16. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
Qiu F; Li T; Zhang K; Wan J; Qi X
Int Immunopharmacol; 2016 Sep; 38():31-9. PubMed ID: 27235595
[TBL] [Abstract][Full Text] [Related]
17. IL-10 regulates murine lupus.
Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
[TBL] [Abstract][Full Text] [Related]
18. Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.
Wu H; Lo Y; Chan A; Law KS; Mok MY
Immunology; 2016 Sep; 149(1):48-61. PubMed ID: 27278094
[TBL] [Abstract][Full Text] [Related]
19. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
[TBL] [Abstract][Full Text] [Related]
20. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.
Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN
J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
